Evidence map›Paper›PMID 42210446›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026

Baseline and interim

Xianwen Hu, Guangyao Yang, Ying Zhao, Pan Wang, Changyin Yu, Jiong Cai, Dongfeng Pan

Abstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xianwen Hu *Department of Nuclear Medicine, The Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563003, People's Republic of China.
Guangyao Yang *Department of Nuclear Medicine, The Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563003, People's Republic of China.
Ying ZhaoDepartment of Nuclear Medicine, The Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563003, People's Republic of China.
Pan WangDepartment of Nuclear Medicine, The Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563003, People's Republic of China.
Changyin YuDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, China. yuchangyin6812@126.com.
Jiong CaiDepartment of Nuclear Medicine, The Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563003, People's Republic of China. jiong_cai@163.com.
Dongfeng PanDepartment of Nuclear Medicine, The Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563003, People's Republic of China. Dong_feng1960@163.com.

Funding

Guizhou Provincial Basic Research Program Qiankehe-ZK[2024]-329Guizhou Provincial Health Commission Science and Technology Fund gzwkj2025-480Medical and research Union Fund for High-quality health development of Guizhou Province 2024GZYXKYJJXM0060National Natural Science Foundation of China 82460264
6 · The paper itself

Abstract

purposeTo investigate the prognostic value of baseline and interim Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (

methodsA single-center retrospective study included adult patients with HL who underwent baseline and interim

resultsA total of 116 patients were included (81 males, 35 females), with a median age of 35 years and a median follow-up of 44 months (IQR 37-58). ROC analysis first established the individual prognostic performance and optimal cut-off values for PET parameters, with interim MTV and TLG achieving AUCs of 0.891 and 0.896 for OS, respectively (cut-offs: 21.8 cm³ and 94.4 g). Subsequently, multivariable Cox regression identified baseline MTV, interim MTV, and the Deauville score as significant independent predictors of PFS. Finally, based on these independent factors, combined models were evaluated; however, they yielded AUCs of 0.901 (95% CI: 0.857-0.943) for OS and 0.824 (95% CI: 0.745-0.902) for PFS, which showed comparable efficacy and did not significantly surpass the predictive power of individual quantitative metrics. While similar trends for interim MTV and the Deauville score were observed for OS, the analysis was constrained by the small number of death events.

conclusionBaseline and interim

Indexed as

Fluorodeoxyglucose F18Hodgkin DiseasePositron Emission Tomography Computed TomographyAdultAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMaleMiddle AgedPrognosisRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTAdults Hodgkin lymphomaMetabolic tumor volumeOverall survivalProgression-free survival

Identifiers

PMID42210446
PMCPMC13418781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.